ellaOne® Receives Prestigious Nicholas Hall & Company Award for the Most Innovative European New Product of the Year
HRA Pharma Closes Investment in Embera NeuroTherapeutics to Advance Development of Novel Therapies for Addiction
Emergency contraceptive pill roll out across Europe brings prescription-free ellaOne® to millions of women
Historic decision from the European Commission grants 120 million women direct access to ellaOne® emergency contraceptive across the European Union.
Ketoconazole HRA® Granted European Marketing Authorisation as an Orphan Drug for the Treatment of Endogenous Cushing’s Syndrome